Anti-Inflammatory Clobetasol Propionate Powder Clobetasol Propionate Raw Material Clobetasol Propionate

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung Clobetasol Propionate
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Clobetasol Propionate
• Name: Clobetasol Propionate Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: 99%
• Specific: COA
• Test Method: HPLC, UV
• CAS: 25122-46-7
• Mf: C25h32clfo5
• MW: 466.97
• Melting Point: 195.5-1970
• Boiling Point: 569.0
• Stability: Stable
• Shelf Life: 2 Years
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 1000kg/Month

Product Description

Anti-Inflammatory Clobetasol Propionate Powder Clobetasol Propionate Raw Material Clobetasol Propionate

Product Description

Product Details

Name	Clobetasol Propionate
CAS NO.	25122-46-7
Molecular formula	C25H32ClFO5
Assay	99%
Characteristic	White crystalline powder
Molecular weight	466.97

Clobetasol belongs to US Class I (Europe: class IV) of the corticosteroids, making it one of the most potent available. It comes in shampoo, mousse, ointment and emollient cream presentations. It has very high potency and typically should not be used with occlusive dressings, or for extended continuous use (beyond two weeks). It is also used to treat several autoimmune diseases including alopecia areata, vitiligo and lichen planus (auto immune skin nodules).

Application&Function

1. Anti-inflammatory effects: The product can reduce and prevent tissue response to inflammation, thereby reducing inflammation performance. Hormone suppression of inflammatory cells, including leukocytes and macrophages accumulation in sites of inflammation and inhibition of phagocytosis, lysosomal enzyme release and synthesis and release of inflammatory chemical mediators. Can reduce and prevent tissue response to inflammation, thereby reducing inflammation performance.

2.Immunosuppressive effect: preventing or inhibiting cell-mediated immune response, delayed hypersensitivity reactions, reducing T lymphocytes, monocytes, eosinophils, reducing immunoglobulin binding to cell surface receptors and inhibition of the synthesis and release of interleukin, thus reducing the T lymphocyte transformation of lymphoblastoid cells, and reduce the extension of the primary immune response. Can reduce immune complexes through the basement membrane, and can reduce the concentration of ingredients complement and immunoglobulins.

Specification